Articles by Brian McLeod
CHAMP's Study Group International mulls IPO
CHAMP Private Equity-owned Australian education services provider Study Group International is reportedly exploring a listing on the Australian Stock Exchange in June, and has appointed Deutsche Bank and Credit Suisse as joint lead managers.
IFC to support Indian hydro with AD Hydro Power
The World Bank’s private investment arm, International Finance Corporation (IFC) has announced it will extend $15 million of equity and $67 million of debt to AD Hydro Power Ltd., a 192-MW project in Himachal Pradesh under joint development by Bhilwara...
PEP powers up control
At first glance, Australian private equity major Pacific Equity Partners’ (PEP) determined takeover bid for Australian renewable energy company Energy Developments (ENE) – even though it has recently expanded its shareholding to more than 50% after buying...
Nature Elements targets $400m for PRC cleantech
In yet another sign-of-the-times development, Nature Elements Capital, a Chinese investment firm founded by KK Chan, has announced that it will raise up to $400 million in a new China clean energy private equity fund.
Yes Bank and GEF to co-pilot new cleantech fund
Copenhagen discord aside, investors are said to be flocking to top up a new $200 million clean/green technology fund to be jointed administered by Indian private bank Yes Bank and noted US-based private equity player Global Environment Fund (GEF), recently...
Private equity now in Oz rugby scrum
The resolution of the hotly-contested licensing of the new fifth Australian Super 15 rugby club known as the Australian Rugby Union (ARU), owned by the Melbourne Rebels consortium, has kicked off speculation that private equity will be a new player to...
Private equity activity freeze thaws in Asia
AVCJ focuses on LP views of the region’s attractions looking ahead into 2010
Anticlimax in Copenhagen
The long-awaited Copenhagen climate conference delivered much sound and fury – but few substantive results.
LP terms of endearment
LP views differ re the value of private equity to their portfolios; but all agree they want – and expect to get – better terms in their relationships with GPs going forward.